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journal homepage: www.j fma-onl ine.comLETTER TO THE EDITORComments on “Effectiveness and safety of
extracranial carotid stent placement: A
nationwide self-controlled case-series study”Dear Editor,
We read the recent report by Chang et al1 with great in-
terest. The investigators retrospectively analyzed data
from the Taiwan’s National Health Insurance claims data-
base between 2005 and 2008 to explore the effectiveness
and safety of carotid artery stenting (CAS) for patients with
carotid artery stenosis. A total of 1258 patients were
enrolled. Within 1 year after CAS, 74 patients died and 80
patients developed ischemic stroke. The investigators
found that the use of statin was associated with a reduced
risk in the 1st month, whereas CAS performed by low-
volume operators was associated with a twofold increased
risk. Several points, if not flaws, warrant further discussion
before readers can accept the results and conclusion.
First, there is a major inconsistency in the patient pop-
ulation. In Figure 1 of their article,1 the study flow began
with “diabetic patients aged  20 years.” However, in the
first paragraph of the “Results” section, it was stated that
37% of patients had diabetes. In our previous study, the
prevalence of diabetes was around 34%.2 It is of utmost
importance to clarify the patient population before further
analysis on this study is worthwhile. Second, the statement
“nine different types of stents” is incorrect. Only six stents
have been approved for carotid indication in Taiwan by the
Department of Health. Supplementary Table 1 of their
article1 erroneously duplicated some of the stent types as
the manufacturers have changed or the types were merely
listed under different delivery systems. Third, Taiwan’s
National Health Insurance has provided coverage for CAS
since July 2004. Patients in Chang et al’s1 report may have
undergone self-paid CAS prior to this time point without any
records being in the database. The claim by the authors to
exclude procedures done prior to 2004 in the same patient,Conflicts of interest: The authors have no conflicts of interest to
declare.
http://dx.doi.org/10.1016/j.jfma.2014.12.007
0929-6646/Copyright ª 2015, Formosan Medical Association. Publishedtherefore, is impossible and should be addressed as a lim-
itation. It is also impossible to differentiate among the in-
dications for CAS, due to either restenosis of previously
treated vessels or a newly developed lesion over the
contralateral internal carotid artery. Therefore, the
statement “first-time CAS recipients” should be interpreted
with great caution. Lastly, the exclusion of patients with
the diagnosis of atrial flutter/fibrillation is unjustifiable and
possibly just a compromise of the methods. We urge the
Journal and authors to clarify these critical points.
References
1. Chang C-H, Lin J-W, Lin C-H, Chen H-C, Hwang J-J, Lai M-S.
Effectiveness and safety of extracranial carotid stent place-
ment: a nationwide self-controlled case-series study. J Formos
Med Assoc 2015;114:274e81.
2. Wu YW, Lin MS, Lin YH, Chao CL, Kao HL. Prevalence of
concomitant atherosclerotic arterial diseases in patients with
significant cervical carotid artery stenosis in Taiwan. Int J Car-
diovasc Imaging 2007;23:433e9.
Chi-Sheng Hung
Mao-Shin Lin
Ying-Hsien Chen
Hsien-Li Kao*
Department of Internal Medicine, National Taiwan
University Hospital, Taipei, Taiwan
*Corresponding author. Department of Internal Medicine,
National Taiwan University Hospital, Number 7, Chung-Shan
South Road, Taipei, Taiwan.
E-mail address: hsienli_kao@yahoo.com (H.-L. Kao)
21 November 2014by Elsevier Taiwan LLC. All rights reserved.
